Effect of zinc oxide quantum dots on methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Staphylococcus aureus (VRSA) isolates from Baghdad Hospital by PCR-technique for mecA and vanA genes

Document Type : Original Research

Authors

1 Department of Nanobiotechnology, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, IranDepartment of Medical Techniques, Faculty of Health and Medical Techniques, Middle Technical University, Baghdad, Iraq

2 Department of Medical Techniques, Faculty of Health and Medical Techniques, Middle Technical University, Baghdad, Iraq

3 Department of Biophysics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran Department of Nanobiotechnology, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran

Abstract
In this study, 50 Staphylococcus aureus samples from Baghdad Hospital were collected and examined, 17 samples were infected with methicillin-resistant Staphylococcus aureus (MRSA) and 5 samples were infected with vancomycin-resistant Staphylococcus aureus (VRSA). The sensitivity of the isolates against different antimicrobial agents was evaluated using the VITEK2 standard system. According to CLSI, the minimum inhibitory concentration (MIC) values of zinc oxide quantum dots (ZnO-QDs) were also tested by the Muller-Hinton dilution method. In addition, polymerase chain reaction (PCR) was performed to identify vanA and mecA genes. The antibacterial effects of ZnO-QDs on VRSA were higher than MRSA isolates.

Keywords

Subjects


1. Rahman, Mary, et al. "Diversity of staphylococci exhibiting high-level resistance to mupirocin." Journal of medical microbiology 33.2 (1990): 97-100.
2. Duckworth, G., J. Lothian, and J. Williams, Methicillin-resistant Staphylococcus aureus: report of an outbreak in a London teaching hospital. Journal of Hospital Infection, 1988. 11(1): p. 1-15.
3. Howden, Benjamin P., et al. "Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications." Clinical microbiology reviews 23.1 (2010): 99-139.
4. Mehrnejad, Faramarz, et al. "PCR-based gene synthesis, molecular cloning, high level expression, purification, and characterization of novel antimicrobial peptide, brevinin-2R, in escherichia coli." Applied biochemistry and biotechnology 149 (2008): 109-118.
5. Chong, Yong Pil, et al. "Clinical and microbiologic analysis of the risk factors for mortality in patients with heterogeneous vancomycin-intermediate Staphylococcus aureus bacteremia." Antimicrobial agents and chemotherapy 59.6 (2015): 3541-3547.
6. Ss, Eshraghi, Pourshafie MR, and Salari MH. "The prevalence and molecular characterization of vancomycin resistant gram positive cocci isolated from patients in Tehran." (2007): 9-15.
7. Lowy, Franklin D. "Antimicrobial resistance: the example of Staphylococcus aureus." The Journal of clinical investigation 111.9 (2003): 1265-1273.
8. Horne, Kylie C., et al. "Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA." Antimicrobial agents and chemotherapy 53.8 (2009): 3447-3452.
9. Dadgostar, Porooshat. "Antimicrobial resistance: implications and costs." Infection and drug resistance (2019): 3903-3910.
10. Shakerimoghaddam, Ali, et al. "Evaluate the effect of zinc oxide and silver nanoparticles on biofilm and icaA gene expression in methicillin-resistant Staphylococcus aureus isolated from burn wound infection." Journal of Burn Care & Research 41.6 (2020): 1253-1259.
11. Jesline, A., et al. "Antimicrobial activity of zinc and titanium dioxide nanoparticles against biofilm-producing methicillin-resistant Staphylococcus aureus." Applied Nanoscience 5 (2015): 157-162.
12.Mihăescu, G. "Zno nanoparticles-modified dressings to inhibit wound pathogens." Materials 14 (2021): 3084.
13. Siddiqi, Khwaja Salahuddin, et al. "Properties of zinc oxide nanoparticles and their activity against microbes." Nanoscale research letters 13 (2018): 1-13.
14. Yamamoto, Osamu. "Influence of particle size on the antibacterial activity of zinc oxide." International Journal of Inorganic Materials 3.7 (2001): 643-646.
15. Valizadeh, Alireza, et al. "Quantum dots: synthesis, bioapplications, and toxicity." Nanoscale research letters 7 (2012): 1-14.
16. Spanhel, Lubomir, and Marc A. Anderson. "Semiconductor clusters in the sol-gel process: quantized aggregation, gelation, and crystal growth in concentrated zinc oxide colloids." Journal of the American Chemical Society 113.8 (1991): 2826-2833.
17. Salehzadeh, Ali, et al. "Molecular typing of nosocomial Staphylococcus aureus strains associated to biofilm based on the coagulase and protein A gene polymorphisms." Iranian journal of basic medical sciences 19.12 (2016): 1325.
18. Ling, Thomas KW, Z. K. Liu, and Augustine FB Cheng. "Evaluation of the VITEK 2 system for rapid direct identification and susceptibility testing of gram-negative bacilli from positive blood cultures." Journal of clinical microbiology 41.10 (2003): 4705-4707.
19. Ghaheri, M., et al. "A comparative evaluation of four DNA extraction protocols from whole blood sample." Cellular and Molecular Biology 62.3 (2016): 120-124.
20. Grare, Marion, et al. "Tetrazolium salts for MIC determination in microplates: Why? Which salt to select? How?." Journal of microbiological methods 75.1 (2008): 156-159.
21. Gebremedhin, Endrias Zewdu, et al. "Isolation and identification of Staphylococcus aureus from milk and milk products, associated factors for contamination, and their antibiogram in Holeta, Central Ethiopia." Veterinary Medicine International 2022 (2022).
22. Feyissa, Negassa, et al. "Isolation, identification, and determination of antibiogram characteristics of Staphylococcus aureus in cow milk and milk products (yoghurt and cheese) in West Showa Zone, Ethiopia." International Dairy Journal 137 (2023): 105503.
23. Mosselhy, Dina A., et al. "Nanotheranostics: a possible solution for drug-resistant Staphylococcus aureus and their biofilms?." Nanomaterials 11.1 (2021): 82.